申请人:CalyGene Biotechnolgy, Inc.
公开号:US20200352921A1
公开(公告)日:2020-11-12
The new arylsulfonamide and arylsulfone derivatives are modulators of TRPML and are useful in treating disorders related to TRPML activities and lysosome functions such as acid-related disorders and cancer.